Public Response to a Proposed Field Trial of Genetically Engineered Mosquitoes in the United States.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 28810013.
- Also identified by DOI 10.1001/jama.2017.9285 and PMC identifier 5817561.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study assesses public response to a proposed field trial in the United States of genetically engineered mosquito (OX513A) designed to suppress wild-type <i>Aedes aegypti</i> mosquitoes, which can transmit diseases such as Zika, dengue, and chikungunya.
Medical subject headings
- Aedes
- Animals, Genetically Modified
- Genetic Engineering
- Mosquito Control
- Public Opinion